Sabri Barutca

Aydin, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017-2025).

Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017-2025).

Journal: Cancer investigation

Published: January 13, 2026

Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).

Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).

Journal: BMC cancer

Published: October 22, 2025

An Experimental Study on the Widely Used Chemotherapeutic Docetaxel: Does It Induce Inflammation, Ischemia, and Neurodegeneration in the Eye, Causing Dry Eye and Blurred Vision in a Real-Life Scenario?

An Experimental Study on the Widely Used Chemotherapeutic Docetaxel: Does It Induce Inflammation, Ischemia, and Neurodegeneration in the Eye, Causing Dry Eye and Blurred Vision in a Real-Life Scenario?

Journal: Current eye research

Published: October 22, 2025

Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).

Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).

Journal: BMC cancer

Published: October 22, 2025

Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis.

Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis.

Journal: Oncology research and treatment

Published: June 22, 2025

Proliferation-Guided Risk Stratification in HER2-Low versus HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis.

Proliferation-Guided Risk Stratification in HER2-Low versus HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis.

Journal: Oncology research and treatment

Published: June 22, 2025

The Role of PET-CT in Cancer Patients Aged 85 and Older: A Tool for Precision or Overutilisation.

The Role of PET-CT in Cancer Patients Aged 85 and Older: A Tool for Precision or Overutilisation.

Journal: Journal of medical imaging and radiation oncology

Published: April 12, 2025

Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in Türkiye.

Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in Türkiye.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 03, 2025

The efficacy of HDDPiW-jSB solution on docetaxel-induced alopecia of rats.

The efficacy of HDDPiW-jSB solution on docetaxel-induced alopecia of rats.

Journal: Cutaneous and ocular toxicology

Published: January 05, 2024

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods.

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods.

Journal: Research square

Published: November 14, 2023

The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors.

The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors.

Journal: Future oncology (London, England)

Published: September 05, 2022

Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab.

Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Published: May 13, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026